HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$8.57
Day range
$8.53 - $8.87
Year range
$6.50 - $18.98
Market cap
906.38M USD
Avg Volume
1.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 28.00M | -80.69% |
Operating expense | 28.00M | -12.50% |
Net income | -112.00M | -2,700.00% |
Net profit margin | -400.00 | -14,392.75% |
Earnings per share | -1.14 | -714.22% |
EBITDA | -119.00M | -1,800.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 997.00M | 0.20% |
Total assets | 1.16B | -10.60% |
Total liabilities | 625.00M | 6.66% |
Total equity | 531.00M | — |
Shares outstanding | 105.89M | — |
Price to book | 1.71 | — |
Return on assets | -26.45% | — |
Return on capital | -48.57% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -112.00M | -2,700.00% |
Cash from operations | -132.00M | -6,500.00% |
Cash from investing | 32.00M | 118.93% |
Cash from financing | 142.00M | -37.99% |
Net change in cash | 42.00M | -27.59% |
Free cash flow | -88.88M | -302.56% |
About
Founded
2015
Website
Employees
627
